198 related articles for article (PubMed ID: 10952436)
1. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
Vokes EE; Haraf DJ; Kies MS
Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging standards of concomitant chemoradiotherapy.
Adelstein DJ; Rodriguez CP
Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiotherapy: emerging treatment improvement strategies.
Milas L; Mason KA; Liao Z; Ang KK
Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
[TBL] [Abstract][Full Text] [Related]
4. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapeutic management of locally advanced head and neck cancer.
Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
7. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
Inuyama Y; Fukuda S; Horiuchi M
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
Bernier J; Cooper JS
Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
[TBL] [Abstract][Full Text] [Related]
9. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy with concomitant chemotherapy for head and neck cancer.
Vokes EE; Awan AM; Weichselbaum RR
Hematol Oncol Clin North Am; 1991 Aug; 5(4):753-67. PubMed ID: 1890065
[TBL] [Abstract][Full Text] [Related]
11. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
13. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
Taguchi T; Tsukuda M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
[TBL] [Abstract][Full Text] [Related]
14. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemotherapy and "concomitant boost" radiotherapy for unresectable head and neck cancer.
Teh BS; Monga U; Thornby J; Gressot L; Parke RB; Donovan DT
Am J Otolaryngol; 2000; 21(5):306-11. PubMed ID: 11032294
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
Salama JK; Vokes EE
Semin Oncol; 2008 Jun; 35(3):251-61. PubMed ID: 18544440
[TBL] [Abstract][Full Text] [Related]
18. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.
Matzinger O; Zouhair A; Mirimanoff RO; Ozsahin M
Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):525-31. PubMed ID: 19535232
[TBL] [Abstract][Full Text] [Related]
19. The chemoradiation paradigm in head and neck cancer.
Seiwert TY; Salama JK; Vokes EE
Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
[TBL] [Abstract][Full Text] [Related]
20. [Role of Chemotherapy in head and neck cancer].
Kohno N; Kitahara S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
